ACLARION, INC. Gain (Loss) on Sale of Properties
ACLARION, INC. (ACON) reported Gain (Loss) on Sale of Properties of $1.89 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2022-08-15
- 2022-06-30: Gain (Loss) on Sale of Properties 6 month $1.89K.
| Period end | Gain (Loss) on Sale of Properties 6 month |
|---|---|
| 2022-06-30 | $1.89K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |